Literature DB >> 3541587

Effect of glycemic control on microvascular complications in patients with type I diabetes mellitus.

J Rosenstock, T Friberg, P Raskin.   

Abstract

The relation between the control of blood glucose levels and the progression of early diabetic retinopathy and the width of skeletal muscle capillary basement membrane was studied in 54 insulin-dependent diabetic patients. After initial ophthalmologic evaluation including seven-field fundus photography and fluorescein angiography and measurement of levels of glycosylated hemoglobin and width of skeletal muscle capillary basement membrane, the patients were divided into two groups: an experimental group of 30 patients who were treated with continuous subcutaneous insulin infusion and a control group of 24 patients who continued to receive conventional treatment--usually two injections of insulin daily. After a mean follow-up period of 31.4 months, the experimental group had a significant decrease in glycosylated hemoglobin levels as compared with baseline values (mean +/- SEM, 7.2 +/- 0.3 percent versus 10.1 +/- 0.4 percent), reflecting improved control of blood glucose levels. The conventional treatment group had no change in glycosylated hemoglobin levels after a mean of 33.5 months of follow-up. With use of either a modified Early Treatment Diabetic Retinopathy Study grading system or macular microaneurysm counts, the experimental treatment group showed significantly less progression of retinopathy (p less than 0.05). The skeletal muscle capillary basement membrane width was significantly reduced only in the experimental treatment group with stable or improved retinopathy and was unchanged in the control group. There was a tendency for skeletal muscle capillary basement membrane width to increase in thickness over time in those patients whose retinopathy worsened irrespective of treatment. It is concluded that meticulous diabetic control may slow the progression of early diabetic retinopathy. Changes in skeletal muscle capillary basement membrane width may reflect the course of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3541587     DOI: 10.1016/0002-9343(86)90398-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy.

Authors:  T W Gardner
Journal:  Trans Am Ophthalmol Soc       Date:  1995

2.  Glucose Control and Diabetic Complications: Is tight control of IDDM justified?

Authors:  S Lubin
Journal:  Can Fam Physician       Date:  1991-06       Impact factor: 3.275

Review 3.  Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.

Authors:  Samantha K Coleman; Irena A Rebalka; Donna M D'Souza; Thomas J Hawke
Journal:  World J Diabetes       Date:  2015-12-10

4.  Central macular thickness in patients with type 2 diabetes mellitus without clinical retinopathy.

Authors:  Mehmet Demir; Ersin Oba; Burcu Dirim; Erhan Ozdal; Efe Can
Journal:  BMC Ophthalmol       Date:  2013-04-09       Impact factor: 2.209

5.  Cental Macular Thickness in Patients with Type 2 Diabetes Mellitus without Clinical Retinopathy.

Authors:  Mehmet Demir; Burcu Dirim; Zeynep Acar; Murat Yılmaz; Yekta Sendul
Journal:  J Ophthalmol       Date:  2013-04-03       Impact factor: 1.909

6.  The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies.

Authors:  Waseem Abu-Ashour; Laurie Twells; James Valcour; Amy Randell; Jennifer Donnan; Patricia Howse; John-Michael Gamble
Journal:  BMJ Open Diabetes Res Care       Date:  2017-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.